According to Henry Schein 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 16.5367. At the end of 2021 the company had a P/E ratio of 17.2.
Year | P/E ratio | Change |
---|---|---|
2021 | 17.2 | |
2019 | 14.1 | -19.38% |
2018 | 17.5 | -17.96% |
2017 | 21.3 | 12.2% |
2016 | 19.0 | |
2014 | 19.3 | |
2011 | 12.4 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
![]() IDEXX Laboratories IDXX | 56.0 | 238.70% | ๐บ๐ธ USA |
![]() AmerisourceBergen
ABC | 22.2 | 34.05% | ๐บ๐ธ USA |
![]() Cardinal Health CAH | 47.7 | 188.62% | ๐บ๐ธ USA |
![]() McKesson MCK | 17.7 | 7.22% | ๐บ๐ธ USA |
![]() Patterson Companies
PDCO | 13.4 | -19.08% | ๐บ๐ธ USA |
![]() Allscripts MDRX | 24.6 | 48.64% | ๐บ๐ธ USA |
![]() Owens & Minor
OMI | -39.5 | -339.14% | ๐บ๐ธ USA |
![]() Petco WOOF | 24.1 | 45.96% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.